<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Example of epinephrine infusion (1 microgram/mL) - Adult</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Example of epinephrine infusion (1 microgram/mL) - Adult</h1>
<div class="graphic"><div class="figure"><div class="ttl">Example of epinephrine infusion (1 microgram/mL) - Adult</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33%"></colgroup> <tbody> <tr> <td class="subtitle1" colspan="3">Example of preparation of epinephrine infusion for refractory symptoms of anaphylaxis (adult patient) for emergency/critical care units</td> </tr> <tr> <td class="subtitle2" colspan="3">Final concentration: Epinephrine 1 microgram/mL</td> </tr> <tr> <td class="subtitle3_left_align" colspan="3">Preparation</td> </tr> <tr> <td colspan="3"> <ol> <li><strong>CHECK</strong> vial strength.</li> </ol> </td> </tr> <tr> <td colspan="3"> <ol start="2"> <li>Add 1 milligram of epinephrine to 1 liter bag of 0.9% normal saline <ul> <li>If you have 0.1 mg/mL strength epinephrine (may also be labeled 1:10,000) use 10 mL to deliver 1 mg to bag*</li> <li>If you have 1 mg/mL strength epinephrine (may also be labeled 1:1000) use 1 mL to deliver 1 mg to bag*</li> </ul> </li> </ol> </td> </tr> <tr> <td class="subtitle3_left_align" colspan="3">Administration</td> </tr> <tr> <td class="indent1" colspan="3"> <ul> <li>Start the epinephrine infusion at <strong>0.1 microgram/kg/minute</strong> using a programmable infusion pump while continuously monitoring the patient's cardiac rhythm and blood pressure (ie, approximately 6 to 10 micrograms/minute in most adults).</li> <li>Using a body weight of 80 kg as an example, you can determine the infusion rate to deliver a dose of 0.1 microgram/kg/minute from a 1 microgram/mL bag as follows: <ol class="numbers_no_heading"> <li>Multiply 0.1 microgram/kg/minute dose by 80 kg body weight to determine dose in micrograms/minute (= 8 micrograms/minute).</li> <li>Use this table to convert 8 micrograms/minute to infusion rate of 8 mL/minute (= 480 mL/hour).</li> </ol> </li> <li>Every 2 to 3 minutes, increase the infusion rate by approximately one-half of the starting rate until the blood pressure and perfusion improve. For more detail, refer to the UpToDate topic on emergency treatment of anaphylaxis.</li> <li>In morbidly obese adults, we suggest initiating the infusion using a standard, ie, non-weight-based dose (eg, up to 10 micrograms/minute initially) and titrating to effect.</li> </ul> </td> </tr> <tr> <td class="subtitle2">Adult infusion dose</td> <td class="subtitle2" colspan="2">Administration rate for infusion pump to deliver adult dose shown</td> </tr> <tr> <td class="subtitle3">micrograms per minute</td> <td class="subtitle3">mL per minute</td> <td class="subtitle3">mL per hour</td> </tr> <tr class="centered"> <td>1</td> <td>1</td> <td>60</td> </tr> <tr class="highlight_blue_text centered"> <td>2</td> <td>2</td> <td>120</td> </tr> <tr class="centered"> <td>3</td> <td>3</td> <td>180</td> </tr> <tr class="highlight_blue_text centered"> <td>4</td> <td>4</td> <td>240</td> </tr> <tr class="centered"> <td>5</td> <td>5</td> <td>300</td> </tr> <tr class="highlight_blue_text centered"> <td>6</td> <td>6</td> <td>360</td> </tr> <tr class="centered"> <td>7</td> <td>7</td> <td>420</td> </tr> <tr class="highlight_blue_text centered"> <td>8</td> <td>8</td> <td>480</td> </tr> <tr class="centered"> <td>9</td> <td>9</td> <td>540</td> </tr> <tr class="highlight_blue_text centered"> <td>10</td> <td>10</td> <td>600</td> </tr> <tr class="centered"> <td>11</td> <td>11</td> <td>660</td> </tr> <tr class="highlight_blue_text centered"> <td>12</td> <td>12</td> <td>720</td> </tr> <tr class="centered"> <td>13</td> <td>13</td> <td>780</td> </tr> <tr class="highlight_blue_text centered"> <td>14</td> <td>14</td> <td>840</td> </tr> <tr class="centered"> <td>15</td> <td>15</td> <td>900</td> </tr> <tr class="highlight_blue_text"> <td class="centered">16</td> <td class="centered">16</td> <td class="centered">960</td> </tr> <tr> <td colspan="3"> <ul> <li>The above table is provided as an example. There are other acceptable concentrations. If there is a risk of volume overload, this dilute solution should only be used as a temporizing measure until a more concentrated solution (eg, 4 micrograms/mL) is available.</li> <li>Intravenous epinephrine, like all vasopressors, can cause life-threatening hypertension, cardiac ischemia, and ventricular arrhythmias. It should be administered <strong>only</strong> by clinicians trained and experienced in dose titration of intravenous epinephrine using continuous noninvasive electronic monitoring of heart rate and blood pressure.</li> <li>Epinephrine is an ischemia-causing agent and vesicant. Monitor infusion site for extravasation. Central venous catheter administration is preferred when available. Refer to the Lexicomp drug reference for information on managing extravasation including infiltration of phentolamine.</li> <li>To reduce the risk of making a medication error, we suggest that centers have available an institutionally approved protocol for epinephrine infusion that includes steps on how to prepare and administer the infusion by programmable infusion pump and standard concentration(s).</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes">* Unused diluted solutions should be discarded within 24 hours or less of preparation, depending on local standards.</div><div class="graphic_reference">References:
<ol>
<li>Gahart BL, Nazareno AR, Ortega MQ. Gahart's 2016 Intravenous Medications: A Handbook for Nurses and Health Professionals, 32nd ed, Elsevier-Mosby, St. Louis, MO.</li>
<li>Lieberman P, Nicklas RA, Oppenheimer J, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010; 126:477.</li>
</ol></div><div id="graphicVersion">Graphic 106917 Version 7.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
